Cargando…

Increased Expressions of Matrix Metalloproteinases (MMPs) in Prostate Cancer Tissues of Men with Type 2 Diabetes

Type 2 diabetes (T2D) is associated with worse prognosis of prostate cancer (PCa). The molecular mechanisms behind this association are still not fully understood. The aim of this study was to identify key factors, which contribute to the more aggressive PCa phenotype in patients with concurrent T2D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franko, Andras, Berti, Lucia, Hennenlotter, Jörg, Rausch, Steffen, Scharpf, Marcus O., de Angelis, Martin Hrabĕ, Stenzl, Arnulf, Peter, Andreas, Birkenfeld, Andreas L., Lutz, Stefan Z., Häring, Hans-Ulrich, Heni, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696165/ https://www.ncbi.nlm.nih.gov/pubmed/33207809 http://dx.doi.org/10.3390/biomedicines8110507

Ejemplares similares

Transcript Levels of Aldo-Keto Reductase Family 1 Subfamily C (AKR1C) Are Increased in Prostate Tissue of Patients with Type 2 Diabetes
por: Franko, Andras, et al.
Publicado: (2020)

Characterization of Hormone-Dependent Pathways in Six Human Prostate-Cancer Cell Lines: A Gene-Expression Study
por: Franko, Andras, et al.
Publicado: (2020)

Human Prostate Cancer Is Characterized by an Increase in Urea Cycle Metabolites
por: Franko, Andras, et al.
Publicado: (2020)

Diabetes and the Prostate: Elevated Fasting Glucose, Insulin Resistance and Higher Levels of Adrenal Steroids in Prostate Cancer
por: Lutz, Stefan Zoltán, et al.
Publicado: (2022)

Multifaceted role of matrix metalloproteinases (MMPs)
por: Singh, Divya, et al.
Publicado: (2015)

Androgen receptor overexpression in prostate cancer in type 2 diabetes
por: Lutz, Stefan Zoltán, et al.
Publicado: (2017)

Matrix Metalloproteinases (MMPs) and Inhibitors of MMPs in the Avian Reproductive System: An Overview
por: Hrabia, Anna
Publicado: (2021)

Insulin Receptor Isoforms A and B as well as Insulin Receptor Substrates-1 and -2 Are Differentially Expressed in Prostate Cancer
por: Heni, Martin, et al.
Publicado: (2012)

Matrix metalloproteinases (MMP’s) in the rat scoliotic intervertebral disc
por: Grivas, Theodoros B, et al.
Publicado: (2010)

Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases
por: Maas, Moritz, et al.
Publicado: (2023)

Bezafibrate Reduces Elevated Hepatic Fumarate in Insulin-Deficient Mice
por: Franko, Andras, et al.
Publicado: (2022)

Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastases
por: Aufderklamm, Stefan, et al.
Publicado: (2021)

Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis
por: Robert, Sacha, et al.
Publicado: (2016)

Assessment of Selected Matrix Metalloproteinases (MMPs) and Correlation with Cytokines in Psoriatic Patients
por: Michalak-Stoma, Anna, et al.
Publicado: (2021)

ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients
por: Glazewska, Edyta K., et al.
Publicado: (2018)

MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
por: Fisel, Pascale, et al.
Publicado: (2015)

Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
por: Büttner, Florian, et al.
Publicado: (2018)

Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs)
por: Okazaki, Isao, et al.
Publicado: (2014)

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2014)

The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinoma
por: Stühler, Viktoria, et al.
Publicado: (2021)

Imbalances between Matrix Metalloproteinases (MMPs) and Tissue Inhibitor of Metalloproteinases (TIMPs) in Maternal Serum during Preterm Labor
por: Tency, Inge, et al.
Publicado: (2012)

Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma
por: Grzelczyk, Weronika Lucas, et al.
Publicado: (2019)

Increased Matrix Metalloproteinase (MMPs) Levels Do Not Predict Disease Severity or Progression in Emphysema
por: D’Armiento, Jeanine M., et al.
Publicado: (2013)

Role of matrix metalloproteinases (MMPs) and MMP inhibitors on intracranial aneurysms: a review article
por: Maradni, Azam, et al.
Publicado: (2013)

Matrix metalloproteinases (MMPs) mediate leukocyte recruitment during the inflammatory phase of zebrafish heart regeneration
por: Xu, Shisan, et al.
Publicado: (2018)

Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases
por: Trentini, Alessandro, et al.
Publicado: (2022)

Increased mitochondrial respiration of adipocytes from metabolically unhealthy obese compared to healthy obese individuals
por: Böhm, Anja, et al.
Publicado: (2020)

Assessment of a new point-of-care system for detection of prostate specific antigen
por: Rausch, Steffen, et al.
Publicado: (2016)

Infrared optical imaging of matrix metalloproteinases (MMPs) up regulation following ischemia reperfusion is ameliorated by hypothermia
por: Barber, Philip A, et al.
Publicado: (2012)

Matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of multiple sclerosis: systematic review and meta-analysis
por: Mohammadhosayni, Mina, et al.
Publicado: (2020)

Expression of matrix metalloproteinases (MMPs)−2/-7/-9/-14 and tissue inhibitors of MMPs (TIMPs)−1/-2 in bovine cutaneous fibropapillomas associated with BPV-2 infection
por: Daraban Bocaneti, Florentina, et al.
Publicado: (2022)

Prediction of Glucose Tolerance without an Oral Glucose Tolerance Test
por: Babbar, Rohit, et al.
Publicado: (2018)

Systemic Alterations of Wnt Inhibitors in Patients with Prostate Cancer and Bone Metastases
por: Aufderklamm, Stefan, et al.
Publicado: (2018)

Matrix Metalloproteinases (MMPs) Regulate Fibrin-invasive Activity via MT1-MMP–dependent and –independent Processes
por: Hotary, Kevin B., et al.
Publicado: (2002)

Association between Polymorphisms in the Promoter Regions of Matrix Metalloproteinases (MMPs) and Risk of Cancer Metastasis: A Meta-Analysis
por: Liu, Dan, et al.
Publicado: (2012)

New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies
por: Devy, Laetitia, et al.
Publicado: (2011)

Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?
por: Maas, Moritz, et al.
Publicado: (2021)

Characterization of Genetic Heterogeneity in Recurrent Metastases of Renal Cell Carcinoma
por: Sauter-Meyerhoff, Carolin, et al.
Publicado: (2021)

Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?
por: Bier, Simone, et al.
Publicado: (2018)

Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications
por: Fritsche, Andreas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_95784f14275asbujp0leibl84k